Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Clinical Therapeutics|July 3, 2017
Vigabatrin Lacks Proarrhythmic Potential: Results from a Thorough QT/QTc Study in Healthy VolunteersDwain Tolbert, Susan Reid, Stuart Harris, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
The pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogsI Bekersky, R J Puhl, G Hanson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male ratsI Bekersky, R J Puhl, G Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1980
Renal clearance of salicylic acid and salicyluric acid in the rat and in the isolated perfused rat kidneyI Bekersky, L Fishman, S A Kaplan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1980
Metabolism of salicylic acid in the isolated perfused rat kidney. Interconversion of salicyluric and salicyclic acidsI Bekersky, W A Colburn, L Fishman, et al.
Cancer Letters|August 1, 1986
In utero-exposure to saccharin: a threat?N Cohen-Addad, M Chatterjee, I Bekersky, et al.
Journal of Lipid Research|September 1, 1970
Biochemical site of regulation of bile acid biosynthesis in the ratS Shefer, S Hauser, I Bekersky, et al.
Journal of Clinical Pharmacology|July 4, 2015
An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokineticsDwain Tolbert, Ihor Bekersky, Hui-May Chu, et al.
Journal of Clinical Pharmacology|July 31, 2015
Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactionsDwain Tolbert, Ihor Bekersky, Hui-May Chu, et al.
Pageof 8